← FDA Drug Approvals (Drugs@FDA)

TAZICEF

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1993-10-31

Drug application

FDA Application #

ANDA064032

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAZICEF

Generic name

CEFTAZIDIME

Active ingredients

CEFTAZIDIME

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

1993-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown